Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 5/20 | 0.40 |
| ▸ | TP53 | P04637 | 4/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3240136 | 0.90 | CNR2 (0.36) | LMNAALDH1A1MAPTTP53CNR2 | |
| SCHEMBL3239864 | 0.89 | LMNA (0.37) | LMNAALDH1A1MAPTTP53CNR2 | |
| SCHEMBL3241690 | 0.89 | THRB (0.40) | LMNAMAPTTP53CNR2RXFP1 | |
| SCHEMBL3235095 | 0.88 | CNR2 (0.36) | LMNAALDH1A1MAPTTP53CNR2 | |
| SCHEMBL3245011 | 0.87 | LMNA (0.40) | LMNAALDH1A1MAPTTP53CNR2 | |
| SCHEMBL1044536 | 0.87 | MAPT (0.45) | LMNAALDH1A1MAPTTP53CNR2 | |
| SCHEMBL3243761 | 0.87 | CNR2 (0.37) | LMNACNR2 | |
| SCHEMBL3239569 | 0.86 | LMNA (0.38) | LMNAALDH1A1MAPTTP53CNR2 | |
| SCHEMBL3243374 | 0.85 | LMNA (0.38) | LMNAALDH1A1MAPTTP53CNR2 | |
| SCHEMBL3245273 | 0.84 | MAPT (0.41) | LMNAALDH1A1MAPTTP53CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1564210-B9 | 4-OXOQUINOLINE COMPOUNDS AND UTILIZATION THEREOF AS HIV INTEGRASE INHIBITORS | JAPAN TOBACCO INC (JP) | 2010-03-31 | — | — | EP | claimed |
| EP-1564210-B1 | 4-OXOQUINOLINE COMPOUNDS AND UTILIZATION THEREOF AS HIV INTEGRASE INHIBITORS | JAPAN TOBACCO INC (JP) | 2009-09-16 | — | — | EP | claimed |